Related Experiment Videos
Transjugular liver biopsy--an Australian experience
C Steadman1, C Teague, J Harper
1Department of Gastroenterology, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia.
Australian and New Zealand Journal of Medicine
|December 1, 1988
Summary
Transjugular liver biopsy is effective and safe for patients with contraindications like bleeding disorders. This minimally invasive procedure yields adequate tissue samples for accurate liver disease diagnosis.
Area of Science:
- Hepatology
- Interventional Radiology
- Diagnostic Procedures
Background:
- Standard percutaneous liver biopsy is contraindicated in patients with coagulation disorders and ascites.
- Transjugular liver biopsy offers an alternative approach when percutaneous biopsy is not feasible.
Purpose of the Study:
- To evaluate the efficacy and safety of transjugular liver biopsy.
- To assess the quality of liver tissue samples obtained via the transjugular route.
Main Methods:
- Transjugular liver biopsy performed on 67 patients (1983-87) using a modified Ross trans-septal needle under fluoroscopic guidance.
- Comparison of histological sample area between transjugular and percutaneous biopsy techniques.
- Optimized techniques for sample processing to improve tissue separation from blood clot.
Main Results:
- Successful tissue acquisition in 93% of transjugular biopsies.
- Significantly larger histological sample area in transjugular biopsies (38.2 mm2) compared to percutaneous biopsies (15.9 mm2).
- Diagnosis was altered in 17 patients based on biopsy findings, with four experiencing significant complications and no deaths.
Conclusions:
- Transjugular liver biopsy is an effective and relatively safe procedure for patients with contraindications to percutaneous biopsy.
- The technique yields superior tissue sample size, facilitating accurate histological diagnosis.
- This approach expands diagnostic capabilities in challenging patient populations.